BackGenetics Generation Advancement Overview

Genetics Generation Advancement Receivables

Track Genetics Generation Advancement's receivables ($130M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$127.59M
↑ 17.61% YoYΔ $19.10M vs prior year quarter

Peer trimmed avg / median

Loading

Genetics Generation Advancement Receivables History

Loading

Genetics Generation Advancement vs. peers: Receivables Comparison

Loading

Genetics Generation Advancement Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Genetics Generation Advancement (4160.TWO) FAQ

Genetics Generation Advancement (4160.TWO) currently reports a receivables of $130M as of June 2026. That compares with $110M in the prior-year period — up 17.6% year over year. Use the charts on this page to explore Genetics Generation Advancement's receivables history and peer comparisons.

Genetics Generation Advancement's receivables increased from $110M to $130M — a 17.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Genetics Generation Advancement reported $130M in receivables as of June 2026. That compares with $110M in the prior-year period — up 17.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $130M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Genetics Generation Advancement, and consider following 4160.TWO for alerts when major investors trade the stock.